COVID-19 Research Perspective Volume 12, Issue 8 pp 6492—6510

Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections

Figure 4. The timing of the administration of geroprotectors for prevention, treatment and rehabilitation of gerolavic respiratory diseases.